ANI vs Denali Therapeutics
ANI vs Denali Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ANI is on 36/100 and Denali Therapeutics on 70/100.
Where each one leads
ANI
- funding raised: $3.4B against $1.0B
Denali Therapeutics
- our overall score: 70/100 against 36/100
- agent readiness: 39/100 against 31/100
At a glance
| Measure | ANI | Denali Therapeutics |
|---|---|---|
| What it is | Diversified biopharmaceutical company focused on rare diseases and generics. | Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier. |
| Category | Biopharmaceutical, Rare Disease, Ophthalmology, Generics | Biotech, HealthTech, Drug Discovery, Neurotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Platform |
| Founded | 1981 | 2015 |
| Headquarters | Princeton, United States | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | ANI | Denali Therapeutics |
|---|---|---|
| Employees | 710 | Not published |
| Total funding | $3.4B | $1.0B |
| Latest round | Seed | Royalty Funding |
| LinkedIn followers | 31,843 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ANI | Denali Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 36/100 | 70/100 |
| Traction | 60/100 | Not published |
| Team | 30/100 | 36/100 |
| Search visibility | 22/100 | Not published |
| Quality | 30/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (31/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 56/100 | 57/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ANI | Denali Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Jquery, Bootstrap | Tailwind CSS |
| Analytics | Google Analytics 4 | Segment |
ANI vs Denali Therapeutics: common questions
Which is better, ANI or Denali Therapeutics?
On our 0-100 score Denali Therapeutics rates higher (70/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do ANI and Denali Therapeutics compare on the numbers?
ANI leads on funding raised ($3.4B against $1.0B). Denali Therapeutics leads on our overall score (70/100 against 36/100), agent readiness (39/100 against 31/100).
Read the full ANI review and pricing or the Denali Therapeutics review and pricing. You can also browse other ANI alternatives we track.